出版与投稿信息
学术表现
- 收录论文量
- 524
- 累计被引
- 9,385
期刊简介
Cancer Drug Resistance (CDR) 是一本国际同行评议、开放获取的在线期刊，由 OAE Publishing Inc. 出版。期刊主要发表研究文章、综述、评论和书信，聚焦药物耐药及其逆转的药理学方面，涵盖药物设计、药物递送、药物分布与细胞耐药等主题。该刊采用单盲同行评审，坚持严格的伦理规范与学术标准。
刊发范围
该期刊发表关于药物耐药及其逆转的药理学方面的研究文章、综述、评论和信件，涵盖药物设计、药物递送、药物分布和细胞耐药等主题。
编委与公开成员
编委团队
汇聚学科专家、审稿资源与国际合作网络，持续支撑期刊选题组织与稿件质量建设。
GoWaElBaHaSuYeMaStCl
Godefridus J. Peters
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Editor-in-Chief
查看主页
Wafik S. El-Deiry
Legorreta Cancer Center, Brown University, Providence, RI, USA.
Deputy Editors
查看主页
Elisa Giovannetti
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Pharmacology Lab, Fondazione Pisana per la Scienza, Pisa, Italy.
Deputy Editors
查看主页
Pa
ChPaola Perego
Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Deputy Editors
Chiara Riganti
Department of Oncology, University of Torino, Torino, Italy.
Deputy Editors
查看主页
Baiyong Shen
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Deputy Editors
查看主页
Hailin Tang
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Deputy Editors
查看主页
Suresh V. Ambudkar
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Editorial Board Members
查看主页
Yehuda G. Assaraf
Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Editorial Board Members
查看主页
Maria R. Baer
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Editorial Board Members
查看主页
Stergios Boussios
Faculty of Life Sciences and Medicine, King's College London, London, UK.
Editorial Board Members
查看主页
Claudio Cerchione
Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Editorial Board Members
查看主页
高影响论文
- 1Drug resistance and combating drug resistance in cancer2019Histone Deacetylase Inhibitors ResearchDOI：10.20517/cdr.2019.10
- 2Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review2020Glioma Diagnosis and TreatmentDOI：10.20517/cdr.2020.79
- 3Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance2020Nanoparticle-Based Drug DeliveryDOI：10.20517/cdr.2020.68
- 4How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?2018Adenosine and Purinergic SignalingDOI：10.20517/cdr.2018.02
- 5Mechanisms of chemotherapy resistance in ovarian cancer2022PARP inhibition in cancer therapyDOI：10.20517/cdr.2021.147
- 6Venetoclax resistance: mechanistic insights and future strategies2022Acute Myeloid Leukemia ResearchDOI：10.20517/cdr.2021.125
- 7Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects2023Colorectal Cancer Treatments and StudiesDOI：10.20517/cdr.2022.136
- 8Targeting the PI₃K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer2021Ovarian cancer diagnosis and treatmentDOI：10.20517/cdr.2021.05
- 9Regulation of cancer stem cells in triple negative breast cancer2021Cancer Cells and MetastasisDOI：10.20517/cdr.2020.106
- 10Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics2021Nanoparticle-Based Drug DeliveryDOI：10.20517/cdr.2020.59
洞察
期刊画像
编委阵容
当前公开整理 53 位编委与公开成员，便于作者快速了解期刊的学术支持网络。
研究主题
期刊内容聚焦 药物耐药、耐药逆转、药物设计 等方向，可结合刊发范围与高影响论文进一步判断匹配度。
开放获取
期刊采用开放获取出版模式，作者可继续查看投稿与费用信息。
相关会议
暂未关联会议。